KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Receivables - Other (2016 - 2025)

Astrana Health (ASTH) has disclosed Receivables - Other for 15 consecutive years, with $26.4 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 10.55% to $26.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.4 million through Dec 2025, down 10.55% year-over-year, with the annual reading at $26.4 million for FY2025, 10.55% down from the prior year.
  • Receivables - Other hit $26.4 million in Q4 2025 for Astrana Health, up from $9.9 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $91.2 million in Q3 2022 to a low of $1.1 million in Q3 2024.
  • Historically, Receivables - Other has averaged $19.5 million across 5 years, with a median of $9.8 million in 2021.
  • Biggest five-year swings in Receivables - Other: plummeted 98.35% in 2023 and later skyrocketed 2109.44% in 2024.
  • Year by year, Receivables - Other stood at $9.6 million in 2021, then grew by 20.24% to $11.6 million in 2022, then plummeted by 88.49% to $1.3 million in 2023, then surged by 2109.44% to $29.5 million in 2024, then fell by 10.55% to $26.4 million in 2025.
  • Business Quant data shows Receivables - Other for ASTH at $26.4 million in Q4 2025, $9.9 million in Q3 2025, and $8.7 million in Q2 2025.